Tolerance development to antimitogenic actions of prostacyclin but not of prostaglandin E1 in coronary artery smooth muscle cells
- 1 March 1998
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 345 (2), 213-220
- https://doi.org/10.1016/s0014-2999(98)00022-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogenEuropean Journal of Pharmacology, 1997
- Shear Stress-Induced Release of PGE2and PGI2by Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1996
- Overexpression of Prostacyclin Synthase Inhibits Growth of Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1995
- Inhibition of Restenosis by Beraprost Sodium (a Prostaglandin I2 Analogue) in the Atherosclerotic Rabbit Artery After AngioplastyJournal of Cardiovascular Pharmacology, 1995
- Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonistsBiochemical Journal, 1995
- Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.Heart, 1994
- Smooth Muscle Cells from Rabbit AortaPublished by Springer Nature ,1990
- Prostacyclin analogues reduce ADP‐ribosylation of the α‐subunit of the regulatory Gs‐protein and diminish adenosine (A2) responsiveness of plateletsBritish Journal of Pharmacology, 1987
- Fatty Acids and Their Prostaglandin Derivatives: Inhibitors of Proliferation in Aortic Smooth Muscle CellsScience, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976